Skip to content

Clinical trials

Phase 3 Lung Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Injury Phase: Phase 3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20162
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adrian Hernandez1
Asklepion Pharmaceuticals, LLC1
Belfast Health and Social Care Trust1
Emory University1
Hospital Clinic of Barcelona1
Hospital Universitari de Bellvitge1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Injury6
Acute Lung Injury3
Respiratory Distress Syndrome3
COVID-192
Bronchopulmonary Dysplasia1
Coronaviridae Infections1
Coronavirus Infections1
Lung Diseases1
Nidovirales Infections1
Premature Birth1

Trials

Showing 26 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.